SILVERS JASON (President & CFO) purchased 2K shares of GENERATE BIOMEDICINES, INC. on the open market
Open‑market purchase worth $32.0K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/2/2026ACC: 0001193125-26-085898
Officer· President & CFO
Since Feb 2026
+572.10K
Net shares
Net buyer
$32.0K
Total acquired
3
Open market trades
3B · 0S
5
Total transactions
572.10K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+500.00
Price / share
$16.00
Trade value
$8K
% of position
New position
3/2/2026
0.00→500.00
Common Stock
Indirect
Shares
+500.00
Price / share
$16.00
Trade value
$8K
% of position
New position
3/2/2026
0.00→500.00
Common Stock
Indirect
Shares
+1K
Price / share
$16.00
Trade value
$16K
% of position
New position
3/2/2026
0.00→1K
Total
Net shares
+2K
Net value
$32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/2/2026 | P · Purchase | +500.00 | $16.00 | $8K | New position | 0.00 | 500.00 |
| Common Stock Indirect | 3/2/2026 | P · Purchase | +500.00 | $16.00 | $8K | New position | 0.00 | 500.00 |
| Common Stock Indirect | 3/2/2026 | P · Purchase | +1K | $16.00 | $16K | New position | 0.00 | 1K |
| Total | +2K | $32K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
295.61K shares
Shares
+295.61K
Strike price
16
Held after
295.61K
Exercisable
—
2/26/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
274.49K shares
Shares
+274.49K
Strike price
16
Held after
274.49K
Exercisable
—
2/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock295.61K shares | 2/26/2026 | A · Award | +295.61K | 16 | — | 295.61K |
| Stock Option (Right to Buy) Direct | Common Stock274.49K shares | 2/26/2026 | A · Award | +274.49K | 16 | — | 274.49K |